Skip to main content
iBio, Inc. logo

iBio, Inc. — Investor Relations & Filings

Ticker · IBIO ISIN · US4510332038 LEI · 529900EW4RXUITGKUT34 US Manufacturing
Filings indexed 690 across all filing types
Latest filing 2014-10-28 Annual Report
Country US United States of America
Listing US IBIO

About iBio, Inc.

https://ibioinc.com/

iBio, Inc. is a preclinical-stage biotechnology company that utilizes a proprietary, AI-driven drug discovery platform to develop novel antibody therapeutics. The company focuses on creating next-generation medicines for obesity and cardiometabolic disorders, aiming to enhance metabolic health. Its technology stack integrates artificial intelligence, machine learning, and advanced computational biology to accelerate the discovery and optimization of biopharmaceuticals for difficult-to-drug targets. The company's internal pipeline consists of therapeutic candidates developed using this platform.

Recent filings

Filing Released Lang Actions
10-K/A Filing
Annual Report FY 2014
2014-10-28 English
424B3 Filing
Regulatory Filings
2014-10-20 English
S-1 Filing
Regulatory Filings
2014-10-06 English
10-K Filing
Annual Report FY 2014
2014-09-29 English
SC 13D/A Filing
Major Shareholding Notification
2014-09-29 English
4 Filing
Director's Dealing
2014-09-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.